A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
Market Analysis and Insights: Global Point of Care Infectious Disease Market
The global Point of Care Infectious Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Point of Care Infectious Disease Scope and Market Size
Point of Care Infectious Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Siemens Healthineers
Trivitron Healthcare
F. Hoffmann-La Roche Ltd
Abbott
Quest Diagnostics, Inc
BD & Company
Chembio Diagnostics Inc
Trinity Biotech
Cardinal Health
Bio-Rad Labs Inc.
bioMérieux SA
Thermo Fisher Scientific Inc
Sight Diagnostics Ltd.
Gene POC
Ortho-Clinical Diagnostics
OJ-Bio Ltd.
Point of Care Infectious Disease Breakdown Data by Type
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
Point of Care Infectious Disease Breakdown Data by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Market Analysis and Insights: Global Point of Care Infectious Disease Market
The global Point of Care Infectious Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Point of Care Infectious Disease Scope and Market Size
Point of Care Infectious Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Siemens Healthineers
Trivitron Healthcare
F. Hoffmann-La Roche Ltd
Abbott
Quest Diagnostics, Inc
BD & Company
Chembio Diagnostics Inc
Trinity Biotech
Cardinal Health
Bio-Rad Labs Inc.
bioMérieux SA
Thermo Fisher Scientific Inc
Sight Diagnostics Ltd.
Gene POC
Ortho-Clinical Diagnostics
OJ-Bio Ltd.
Point of Care Infectious Disease Breakdown Data by Type
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
Point of Care Infectious Disease Breakdown Data by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue
1.4 Market by Type
1.4.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 HIV POC
1.4.3 Clostridium difficile POC
1.4.4 HBV POC
1.4.5 Pneumonia or Streptococcus associated infections
1.4.6 Respiratory syncytial virus (RSV) POC
1.4.7 HPV POC
1.4.8 Influenza/Flu POC
1.4.9 HCV POC
1.4.10 MRSA POC
1.4.11 TB and drug-resistant TB POC
1.5 Market by Application
1.5.1 Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home
1.5.5 Assisted Living Healthcare Facilities
1.5.6 Laboratories
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Infectious Disease Market Perspective (2015-2026)
2.2 Global Point of Care Infectious Disease Growth Trends by Regions
2.2.1 Point of Care Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2015-2020)
2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Point of Care Infectious Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Point of Care Infectious Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Infectious Disease Players by Market Size
3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2015-2020)
3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point of Care Infectious Disease Market Concentration Ratio
3.2.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2019
3.3 Point of Care Infectious Disease Key Players Head office and Area Served
3.4 Key Players Point of Care Infectious Disease Product Solution and Service
3.5 Date of Enter into Point of Care Infectious Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2015-2020)
4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Point of Care Infectious Disease Market Size by Application (2015-2020)
5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point of Care Infectious Disease Market Size (2015-2020)
6.2 Point of Care Infectious Disease Key Players in North America (2019-2020)
6.3 North America Point of Care Infectious Disease Market Size by Type (2015-2020)
6.4 North America Point of Care Infectious Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Point of Care Infectious Disease Market Size (2015-2020)
7.2 Point of Care Infectious Disease Key Players in Europe (2019-2020)
7.3 Europe Point of Care Infectious Disease Market Size by Type (2015-2020)
7.4 Europe Point of Care Infectious Disease Market Size by Application (2015-2020)
8 China
8.1 China Point of Care Infectious Disease Market Size (2015-2020)
8.2 Point of Care Infectious Disease Key Players in China (2019-2020)
8.3 China Point of Care Infectious Disease Market Size by Type (2015-2020)
8.4 China Point of Care Infectious Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Point of Care Infectious Disease Market Size (2015-2020)
9.2 Point of Care Infectious Disease Key Players in Japan (2019-2020)
9.3 Japan Point of Care Infectious Disease Market Size by Type (2015-2020)
9.4 Japan Point of Care Infectious Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Point of Care Infectious Disease Market Size (2015-2020)
10.2 Point of Care Infectious Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020)
11 India
11.1 India Point of Care Infectious Disease Market Size (2015-2020)
11.2 Point of Care Infectious Disease Key Players in India (2019-2020)
11.3 India Point of Care Infectious Disease Market Size by Type (2015-2020)
11.4 India Point of Care Infectious Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Point of Care Infectious Disease Market Size (2015-2020)
12.2 Point of Care Infectious Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020)
12.4 Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens Healthineers
13.1.1 Siemens Healthineers Company Details
13.1.2 Siemens Healthineers Business Overview
13.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction
13.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020))
13.1.5 Siemens Healthineers Recent Development
13.2 Trivitron Healthcare
13.2.1 Trivitron Healthcare Company Details
13.2.2 Trivitron Healthcare Business Overview
13.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction
13.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020)
13.2.5 Trivitron Healthcare Recent Development
13.3 F. Hoffmann-La Roche Ltd
13.3.1 F. Hoffmann-La Roche Ltd Company Details
13.3.2 F. Hoffmann-La Roche Ltd Business Overview
13.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction
13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Ltd Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Point of Care Infectious Disease Introduction
13.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 Quest Diagnostics, Inc
13.5.1 Quest Diagnostics, Inc Company Details
13.5.2 Quest Diagnostics, Inc Business Overview
13.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction
13.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
13.5.5 Quest Diagnostics, Inc Recent Development
13.6 BD & Company
13.6.1 BD & Company Company Details
13.6.2 BD & Company Business Overview
13.6.3 BD & Company Point of Care Infectious Disease Introduction
13.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020)
13.6.5 BD & Company Recent Development
13.7 Chembio Diagnostics Inc
13.7.1 Chembio Diagnostics Inc Company Details
13.7.2 Chembio Diagnostics Inc Business Overview
13.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction
13.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
13.7.5 Chembio Diagnostics Inc Recent Development
13.8 Trinity Biotech
13.8.1 Trinity Biotech Company Details
13.8.2 Trinity Biotech Business Overview
13.8.3 Trinity Biotech Point of Care Infectious Disease Introduction
13.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020)
13.8.5 Trinity Biotech Recent Development
13.9 Cardinal Health
13.9.1 Cardinal Health Company Details
13.9.2 Cardinal Health Business Overview
13.9.3 Cardinal Health Point of Care Infectious Disease Introduction
13.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020)
13.9.5 Cardinal Health Recent Development
13.10 Bio-Rad Labs Inc.
13.10.1 Bio-Rad Labs Inc. Company Details
13.10.2 Bio-Rad Labs Inc. Business Overview
13.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction
13.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020)
13.10.5 Bio-Rad Labs Inc. Recent Development
13.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview
10.11.3 bioMérieux SA Point of Care Infectious Disease Introduction
10.11.4 bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
13.12 Thermo Fisher Scientific Inc
10.12.1 Thermo Fisher Scientific Inc Company Details
10.12.2 Thermo Fisher Scientific Inc Business Overview
10.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction
10.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
10.12.5 Thermo Fisher Scientific Inc Recent Development
13.13 Sight Diagnostics Ltd.
10.13.1 Sight Diagnostics Ltd. Company Details
10.13.2 Sight Diagnostics Ltd. Business Overview
10.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction
10.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
10.13.5 Sight Diagnostics Ltd. Recent Development
13.14 Gene POC
10.14.1 Gene POC Company Details
10.14.2 Gene POC Business Overview
10.14.3 Gene POC Point of Care Infectious Disease Introduction
10.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020)
10.14.5 Gene POC Recent Development
13.15 Ortho-Clinical Diagnostics
10.15.1 Ortho-Clinical Diagnostics Company Details
10.15.2 Ortho-Clinical Diagnostics Business Overview
10.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction
10.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020)
10.15.5 Ortho-Clinical Diagnostics Recent Development
13.16 OJ-Bio Ltd.
10.16.1 OJ-Bio Ltd. Company Details
10.16.2 OJ-Bio Ltd. Business Overview
10.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction
10.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
10.16.5 OJ-Bio Ltd. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue
1.4 Market by Type
1.4.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 HIV POC
1.4.3 Clostridium difficile POC
1.4.4 HBV POC
1.4.5 Pneumonia or Streptococcus associated infections
1.4.6 Respiratory syncytial virus (RSV) POC
1.4.7 HPV POC
1.4.8 Influenza/Flu POC
1.4.9 HCV POC
1.4.10 MRSA POC
1.4.11 TB and drug-resistant TB POC
1.5 Market by Application
1.5.1 Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home
1.5.5 Assisted Living Healthcare Facilities
1.5.6 Laboratories
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Infectious Disease Market Perspective (2015-2026)
2.2 Global Point of Care Infectious Disease Growth Trends by Regions
2.2.1 Point of Care Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2015-2020)
2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Point of Care Infectious Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Point of Care Infectious Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Infectious Disease Players by Market Size
3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2015-2020)
3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point of Care Infectious Disease Market Concentration Ratio
3.2.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2019
3.3 Point of Care Infectious Disease Key Players Head office and Area Served
3.4 Key Players Point of Care Infectious Disease Product Solution and Service
3.5 Date of Enter into Point of Care Infectious Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2015-2020)
4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Point of Care Infectious Disease Market Size by Application (2015-2020)
5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point of Care Infectious Disease Market Size (2015-2020)
6.2 Point of Care Infectious Disease Key Players in North America (2019-2020)
6.3 North America Point of Care Infectious Disease Market Size by Type (2015-2020)
6.4 North America Point of Care Infectious Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Point of Care Infectious Disease Market Size (2015-2020)
7.2 Point of Care Infectious Disease Key Players in Europe (2019-2020)
7.3 Europe Point of Care Infectious Disease Market Size by Type (2015-2020)
7.4 Europe Point of Care Infectious Disease Market Size by Application (2015-2020)
8 China
8.1 China Point of Care Infectious Disease Market Size (2015-2020)
8.2 Point of Care Infectious Disease Key Players in China (2019-2020)
8.3 China Point of Care Infectious Disease Market Size by Type (2015-2020)
8.4 China Point of Care Infectious Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Point of Care Infectious Disease Market Size (2015-2020)
9.2 Point of Care Infectious Disease Key Players in Japan (2019-2020)
9.3 Japan Point of Care Infectious Disease Market Size by Type (2015-2020)
9.4 Japan Point of Care Infectious Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Point of Care Infectious Disease Market Size (2015-2020)
10.2 Point of Care Infectious Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020)
11 India
11.1 India Point of Care Infectious Disease Market Size (2015-2020)
11.2 Point of Care Infectious Disease Key Players in India (2019-2020)
11.3 India Point of Care Infectious Disease Market Size by Type (2015-2020)
11.4 India Point of Care Infectious Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Point of Care Infectious Disease Market Size (2015-2020)
12.2 Point of Care Infectious Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020)
12.4 Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens Healthineers
13.1.1 Siemens Healthineers Company Details
13.1.2 Siemens Healthineers Business Overview
13.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction
13.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020))
13.1.5 Siemens Healthineers Recent Development
13.2 Trivitron Healthcare
13.2.1 Trivitron Healthcare Company Details
13.2.2 Trivitron Healthcare Business Overview
13.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction
13.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020)
13.2.5 Trivitron Healthcare Recent Development
13.3 F. Hoffmann-La Roche Ltd
13.3.1 F. Hoffmann-La Roche Ltd Company Details
13.3.2 F. Hoffmann-La Roche Ltd Business Overview
13.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction
13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Ltd Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Point of Care Infectious Disease Introduction
13.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 Quest Diagnostics, Inc
13.5.1 Quest Diagnostics, Inc Company Details
13.5.2 Quest Diagnostics, Inc Business Overview
13.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction
13.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
13.5.5 Quest Diagnostics, Inc Recent Development
13.6 BD & Company
13.6.1 BD & Company Company Details
13.6.2 BD & Company Business Overview
13.6.3 BD & Company Point of Care Infectious Disease Introduction
13.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020)
13.6.5 BD & Company Recent Development
13.7 Chembio Diagnostics Inc
13.7.1 Chembio Diagnostics Inc Company Details
13.7.2 Chembio Diagnostics Inc Business Overview
13.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction
13.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
13.7.5 Chembio Diagnostics Inc Recent Development
13.8 Trinity Biotech
13.8.1 Trinity Biotech Company Details
13.8.2 Trinity Biotech Business Overview
13.8.3 Trinity Biotech Point of Care Infectious Disease Introduction
13.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020)
13.8.5 Trinity Biotech Recent Development
13.9 Cardinal Health
13.9.1 Cardinal Health Company Details
13.9.2 Cardinal Health Business Overview
13.9.3 Cardinal Health Point of Care Infectious Disease Introduction
13.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020)
13.9.5 Cardinal Health Recent Development
13.10 Bio-Rad Labs Inc.
13.10.1 Bio-Rad Labs Inc. Company Details
13.10.2 Bio-Rad Labs Inc. Business Overview
13.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction
13.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020)
13.10.5 Bio-Rad Labs Inc. Recent Development
13.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview
10.11.3 bioMérieux SA Point of Care Infectious Disease Introduction
10.11.4 bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
13.12 Thermo Fisher Scientific Inc
10.12.1 Thermo Fisher Scientific Inc Company Details
10.12.2 Thermo Fisher Scientific Inc Business Overview
10.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction
10.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
10.12.5 Thermo Fisher Scientific Inc Recent Development
13.13 Sight Diagnostics Ltd.
10.13.1 Sight Diagnostics Ltd. Company Details
10.13.2 Sight Diagnostics Ltd. Business Overview
10.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction
10.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
10.13.5 Sight Diagnostics Ltd. Recent Development
13.14 Gene POC
10.14.1 Gene POC Company Details
10.14.2 Gene POC Business Overview
10.14.3 Gene POC Point of Care Infectious Disease Introduction
10.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020)
10.14.5 Gene POC Recent Development
13.15 Ortho-Clinical Diagnostics
10.15.1 Ortho-Clinical Diagnostics Company Details
10.15.2 Ortho-Clinical Diagnostics Business Overview
10.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction
10.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020)
10.15.5 Ortho-Clinical Diagnostics Recent Development
13.16 OJ-Bio Ltd.
10.16.1 OJ-Bio Ltd. Company Details
10.16.2 OJ-Bio Ltd. Business Overview
10.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction
10.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
10.16.5 OJ-Bio Ltd. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
